Auris Medical Holding Ltd

(NASDAQ:EARS)

Latest On Auris Medical Holding Ltd (EARS):

Date/Time Type Description Signal Details
2021-07-21 05:49 ESTNewsAuris Medical soars 10% on acquisition of Trasir Therapeutics and plans for strategic repositioningN/A
2021-07-21 05:39 ESTNewsAuris Medical Holding (EARS) Presents At LD Micro Invitational XI Conference - SlideshowN/A
2021-07-21 05:28 ESTNewsAuris Medical shares rise on OligoPhore Lymphoma study resultsN/A
2021-07-21 05:09 ESTNewsAuris Medical shares rise after picking colorectal cancer as the first indication for OligoPhoreN/A
2021-07-21 04:58 ESTNewsAuris Medical shares surge on data from Bentrio SARS-CoV-2 preclinical studiesN/A
2021-07-21 04:52 ESTNewsAuris Medical launches new corporate websiteN/A
2021-04-13 12:46 ESTNewsAuris Medical (EARS) shares down after providing updates on AM-301 program in allergic rhinitisN/A
2021-04-12 19:00 ESTNewsBABA, MARA, NUAN and CVAC among notable premarket gainersN/A
2021-04-06 19:49 ESTNewsAuris Medical is trading higher on patent winN/A
2021-03-31 20:03 ESTNewsAuris Medical reports FY 2020 resultsN/A
2021-03-31 20:03 ESTNewsAuris Medical net loss widens in FY20, shares down 3%N/A
2020-12-02 20:47 ESTNewsAuris Medical prices $8M direct equity offering, stock -22%N/A
2020-12-01 16:03 ESTNewsAuris Medical soars after AM-301 shows encouraging preclinical action against SARS-CoV-2 infectionN/A
2020-11-26 19:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:40 ESTFinancialsCompany financials have been released.Neutral
2020-10-14 11:33 ESTNewsAuris Medical launches second part of mid-stage study with AM-125 in vertigoN/A
2020-09-26 12:36 ESTFinancialsCompany financials have been released.Neutral
2020-09-22 16:43 ESTFinancialsCompany financials have been released.Neutral
2020-09-18 02:50 ESTNewsAuris Medical reports 1H resultsN/A
2020-09-18 02:50 ESTNewsAuris Medical +5% on 1H resultsN/A
2020-09-18 02:49 ESTNewsAuris Medical Holding Ltd. (EARS) CEO Thomas Meyer on Q2 2020 Results - Earnings Call TranscriptN/A
2020-09-18 02:49 ESTNewsAuris Medical Holding Ltd. 2020 Q2 - Results - Earnings Call PresentationN/A
2020-09-17 04:44 ESTFinancialsCompany financials have been released.Neutral
2020-09-03 19:54 ESTNewsPositive AM-125 data lifts Auris Medical, up 28%N/A
2020-08-14 08:38 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 12:36 ESTAnalyst RatingThe Analyst Target Price has decreased from $15 to $14.95.Neutral
2020-08-10 08:38 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.04 to $15.Neutral
2020-08-08 08:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.07 to $15.04.Neutral
2020-08-07 08:36 ESTAnalyst RatingThe Analyst Target Price has increased from $14.98 to $15.07.Buy
2020-08-06 20:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 08:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $15.06 to $14.98.Neutral
2020-08-01 08:34 ESTAnalyst RatingThe Analyst Target Price has increased from $15 to $15.06.Buy
2020-07-31 08:35 ESTAnalyst RatingThe Analyst Target Price has increased from $14.91 to $15.Buy
2020-07-31 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 16:34 ESTAnalyst RatingThe Analyst Target Price has increased from $14.89 to $14.91.Buy
2020-07-29 20:41 ESTAnalyst RatingThe Analyst Target Price has increased from $14.86 to $14.89.Buy
2020-07-28 20:37 ESTAnalyst RatingThe Analyst Target Price has increased from $14.79 to $14.86.Buy
2020-07-25 08:32 ESTAnalyst RatingThe Analyst Target Price has increased from $14.72 to $14.79.Buy
2020-07-24 20:44 ESTAnalyst RatingThe Analyst Target Price has increased from $14.68 to $14.72.Buy
2020-07-23 16:52 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:52 ESTAnalyst RatingThe Analyst Target Price has increased from $14.48 to $14.68.Buy
2020-07-20 08:33 ESTAnalyst RatingThe Analyst Target Price has increased from $13.69 to $14.48.Buy
2020-07-09 08:34 ESTFinancialsCompany financials have been released.Neutral
2020-07-07 20:35 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.38 to $13.69.Neutral
2020-06-26 08:33 ESTFinancialsCompany financials have been released.Neutral
2020-06-20 08:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.43 to $14.38.Neutral
2020-06-19 08:33 ESTAnalyst RatingThe Analyst Target Price has increased from $14.39 to $14.43.Buy
2020-06-15 20:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.5 to $14.39.Neutral
2020-06-13 00:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $14.77 to $14.5.Neutral
2020-06-12 04:35 ESTFinancialsCompany financials have been released.Neutral

About Auris Medical Holding Ltd (EARS):

Auris Medical Holding Ltd., a development-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment and prevention of peripheral and central nervous disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 that is in Phase 2 clinical trial for the intranasal treatment of acute peripheral vertigo; and AM-201, which is in Phase 1b clinical trial for the prevention of weight gain and drowsiness, which are side effects of various antipsychotic drugs, as well as AM-102 for the tinnitus treatment. The company has a collaboration and license agreement with INSERM; and Xigen S.A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders. Auris Medical Holding Ltd. was founded in 1998 and is headquartered in Hamilton, Bermuda.

EARS Quotes by TradingView

See Advanced Chart

General

  • Name Auris Medical Holding Ltd
  • Symbol EARS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 8
  • Last Split Factor1:20
  • Last Split Date2019-05-01
  • Fiscal Year EndDecember
  • IPO Date2014-08-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aurismedical.com
View More

Valuation

  • Trailing PE 3.38
  • Price/Book (Most Recent Quarter) 9.35
  • Enterprise Value EBITDA 0.12
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Return on Assets -35%
  • Return on Equity -85%
  • Earnings Per Share -$1.33
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 48.98 million
  • Analyst Target Price $14.95
  • Book Value Per Share -$0.03
View More

Share Statistics

  • Shares Outstanding 11.42 million
  • Shares Float 6.79 million
  • % Held by Insiders 605%
  • % Held by Institutions 0.48%
  • Shares Short 110901
  • Shares Short Prior Month 28075
  • Short Ratio 0.09
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.2
  • 52 Week High $5.54
  • 52 Week Low $0.72
  • 50 Day Moving Average 3.56
  • 200 Day Moving Average 2.12
View More

Dividends

  • Dividend Date 2019-05-01
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Auris Medical Holding Ltd (EARS) Dividend Calendar:

EARS's last dividend payment was made to shareholders on May 1, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Auris Medical Holding Ltd (EARS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-03-312020-06-30$N/A-$0.31$0.00
2019-12-312020-03-31$N/A-$0.30$0.00
2019-09-302019-12-31$N/A-$0.43$0.00
2019-06-302019-09-30$N/A-$0.42-$1.6073.99%
2019-03-312019-06-30$N/A-$0.85$0.00
2018-12-312019-03-14$N/A-$0.62-$2.2271.98%
2018-09-302018-11-15$N/A-$2.83-$2.22-27.6%
2018-06-302018-08-15$N/A-$10.21-$32.7968.85%
2018-03-312018-05-15$N/A-$6.41
2017-12-312018-03-22$N/A-$20.26
2017-09-302017-11-28$N/A-$28.18-$28.581.4%
2017-06-302017-08-10$N/A-$31.97-$39.6319.31%
2017-03-312017-05-11$N/A-$42.23-$27.85-51.63%
2016-12-312017-03-14$N/A-$25.97-$57.4954.83%
2016-09-302016-11-10$N/A-$52.10-$57.248.98%
2016-06-302016-08-18$N/A-$52.20-$50.62-3.12%
2016-03-312016-05-11$N/A-$53.59-$46.56-15.09%
2015-12-312016-03-14$N/A-$32.48-$56.1942.2%
2015-09-302015-11-12$N/A-$0.16-$0.2842.86%
2015-06-302015-08-19$N/A-$0.36-$0.23-56.52%
2015-03-312015-05-28$N/A-$0.29-$0.22-31.82%
2014-12-312015-03-19$N/A-$0.16-$0.3554.29%
2014-09-302014-12-03$N/A-$0.15-$0.2744.44%
2014-06-302014-09-15$N/A-$0.30-$0.326.25%

Auris Medical Holding Ltd (EARS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Auris Medical Holding Ltd (EARS) Chart:

Auris Medical Holding Ltd (EARS) News:

Below you will find a list of latest news for Auris Medical Holding Ltd (EARS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Auris Medical Holding Ltd (EARS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Auris Medical Holding Ltd (EARS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020016562/0001213900-20-016562-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000019001770/0000000000-19-001770-index.htm
2019-02-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000019002091/0000000000-19-002091-index.htm
2019-05-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000019008132/0000000000-19-008132-index.htm
2020-05-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000020003954/0000000000-20-003954-index.htm
2020-06-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000020005082/0000000000-20-005082-index.htm
2020-06-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1601936/000000000020005562/0000000000-20-005562-index.htm
2018-11-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010318013929/0000950103-18-013929-index.htm
2018-11-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318013930/0000950103-18-013930-index.htm
2018-11-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318013931/0000950103-18-013931-index.htm
2018-11-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318013932/0000950103-18-013932-index.htm
2018-11-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318013933/0000950103-18-013933-index.htm
2018-12-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014533/0000950103-18-014533-index.htm
2018-12-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014534/0000950103-18-014534-index.htm
2018-12-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014535/0000950103-18-014535-index.htm
2018-12-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014536/0000950103-18-014536-index.htm
2018-12-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014618/0000950103-18-014618-index.htm
2018-12-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014619/0000950103-18-014619-index.htm
2018-12-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010318014900/0000950103-18-014900-index.htm
2019-01-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010319000702/0000950103-19-000702-index.htm
2019-01-17424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010319000705/0000950103-19-000705-index.htm
2019-01-17424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010319000707/0000950103-19-000707-index.htm
2019-01-17424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010319000709/0000950103-19-000709-index.htm
2019-02-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010319001840/0000950103-19-001840-index.htm
2019-02-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010319001980/0000950103-19-001980-index.htm
2019-02-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000095010319001981/0000950103-19-001981-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010319003200/0000950103-19-003200-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010319003392/0000950103-19-003392-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000095010319003393/0000950103-19-003393-index.htm
2019-03-188-K12G3Notification of securities of successor issuers deemed to registered [Section 12]https://www.sec.gov/Archives/edgar/data/1601936/000095010319003452/0000950103-19-003452-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1601936/000101905619000149/0001019056-19-000149-index.htm
2019-01-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000114420419003192/0001144204-19-003192-index.htm
2019-01-29F-4Registration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1601936/000114420419003280/0001144204-19-003280-index.htm
2019-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000114420419003559/0001144204-19-003559-index.htm
2019-01-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000114420419003570/0001144204-19-003570-index.htm
2019-01-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000114420419003572/0001144204-19-003572-index.htm
2019-02-01F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000114420419004218/0001144204-19-004218-index.htm
2019-02-01F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000114420419004476/0001144204-19-004476-index.htm
2019-02-13F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1601936/000114420419007292/0001144204-19-007292-index.htm
2019-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000114420419007299/0001144204-19-007299-index.htm
2019-02-13F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000114420419007320/0001144204-19-007320-index.htm
2019-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000114420419007336/0001144204-19-007336-index.htm
2019-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1601936/000114420419007825/0001144204-19-007825-index.htm
2019-02-15424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000114420419008688/0001144204-19-008688-index.htm
2019-02-20424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000114420419009133/0001144204-19-009133-index.htm
2019-03-20POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390019004564/0001213900-19-004564-index.htm
2019-03-20POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390019004566/0001213900-19-004566-index.htm
2019-04-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019005781/0001213900-19-005781-index.htm
2019-04-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019005812/0001213900-19-005812-index.htm
2019-04-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019005813/0001213900-19-005813-index.htm
2019-04-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019005867/0001213900-19-005867-index.htm
2019-04-05424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019005870/0001213900-19-005870-index.htm
2019-04-11POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390019006153/0001213900-19-006153-index.htm
2019-04-11POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390019006154/0001213900-19-006154-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019007362/0001213900-19-007362-index.htm
2019-04-30F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000121390019007363/0001213900-19-007363-index.htm
2019-05-06F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000121390019007900/0001213900-19-007900-index.htm
2019-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000121390019008035/0001213900-19-008035-index.htm
2019-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000121390019008037/0001213900-19-008037-index.htm
2019-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019008074/0001213900-19-008074-index.htm
2019-05-10F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000121390019008263/0001213900-19-008263-index.htm
2019-05-13F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019008325/0001213900-19-008325-index.htm
2019-05-13POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019008327/0001213900-19-008327-index.htm
2019-05-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019008561/0001213900-19-008561-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019008932/0001213900-19-008932-index.htm
2019-06-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1601936/000121390019010664/0001213900-19-010664-index.htm
2019-06-26RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1601936/000121390019011535/0001213900-19-011535-index.htm
2019-07-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1601936/000121390019013206/0001213900-19-013206-index.htm
2019-08-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1601936/000121390019015255/0001213900-19-015255-index.htm
2019-08-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019015943/0001213900-19-015943-index.htm
2019-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019017179/0001213900-19-017179-index.htm
2019-09-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019017391/0001213900-19-017391-index.htm
2019-09-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019017392/0001213900-19-017392-index.htm
2019-09-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390019017393/0001213900-19-017393-index.htm
2019-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390019020863/0001213900-19-020863-index.htm
2020-01-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020000595/0001213900-20-000595-index.htm
2020-04-1620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1601936/000121390020009292/0001213900-20-009292-index.htm
2020-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020009293/0001213900-20-009293-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020009664/0001213900-20-009664-index.htm
2020-04-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020009945/0001213900-20-009945-index.htm
2020-04-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020009950/0001213900-20-009950-index.htm
2020-04-29F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000121390020010445/0001213900-20-010445-index.htm
2020-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000121390020011343/0001213900-20-011343-index.htm
2020-05-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1601936/000121390020011670/0001213900-20-011670-index.htm
2020-05-26POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390020013378/0001213900-20-013378-index.htm
2020-05-26POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1601936/000121390020013380/0001213900-20-013380-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020014233/0001213900-20-014233-index.htm
2020-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1601936/000121390020015347/0001213900-20-015347-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020016562/0001213900-20-016562-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1601936/000121390020023100/0001213900-20-023100-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020025530/0001213900-20-025530-index.htm
2020-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020026285/0001213900-20-026285-index.htm
2020-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020027043/0001213900-20-027043-index.htm
2020-09-176-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020027077/0001213900-20-027077-index.htm
2020-10-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1601936/000121390020030319/0001213900-20-030319-index.htm
2020-10-06F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1601936/000121390020030341/0001213900-20-030341-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1601936/000121390020030811/0001213900-20-030811-index.htm
2019-05-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1601936/000138713119003910/0001387131-19-003910-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1601936/000138713120001844/0001387131-20-001844-index.htm
2019-03-1420-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1601936/000160193619000008/0001601936-19-000008-index.htm
2019-02-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000289/9999999995-19-000289-index.htm
2019-02-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000292/9999999995-19-000292-index.htm
2019-03-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000530/9999999995-19-000530-index.htm
2019-03-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000532/9999999995-19-000532-index.htm
2019-04-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000753/9999999995-19-000753-index.htm
2019-04-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519000755/9999999995-19-000755-index.htm
2019-05-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999519001088/9999999995-19-001088-index.htm
2020-05-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999520001116/9999999995-20-001116-index.htm
2020-06-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999520001502/9999999995-20-001502-index.htm
2020-06-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999520001503/9999999995-20-001503-index.htm
2020-10-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1601936/999999999520003049/9999999995-20-003049-index.htm